Wnt and β-catenin signaling target the expression of ecto-5′-nucleotidase and increase extracellular adenosine generation

Experimental Cell Research

Volumn 296, Issue 2, 2004, Pages 99-108

  Spychala, Jozef ^a   Kitajewski, Jan ^b  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

Adenosine deaminase; APC; Ecto 5 nucleotidase; Tumor progression; Wnt; catenin

Indexed keywords

ADENOSINE; ADENOSINE DEAMINASE; BETA CATENIN; ECTO 5' NUCLEOTIDASE; MESSENGER RNA; T CELL FACTOR PROTEIN; WNT PROTEIN; WNT1 PROTEIN;

ANIMAL CELL; ARTICLE; BINDING SITE; CANCER CELL; CELL STRAIN COS7; CELL TRANSFORMATION; COLON CARCINOMA; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME ACTIVITY; EXTRACELLULAR SPACE; GENE EXPRESSION; HUMAN; HUMAN CELL; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN METABOLISM; RAT; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; SOLID TUMOR; UTERINE CERVIX CANCER;

ADA; TRIXIS;

EID: 2442478198     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yexcr.2003.11.001     Document Type: Article

References (76)

1. Blay J., White T.D., Hoskin D.W. The extracellular fluid of solid carcinomas contains immunosuppressive concentrations of adenosine. Cancer Res. 57:1997;2602-2605
2. Weisman G.A., Lustig K.D., Lane E., Huang N.N., Belzer I., Friedberg I. Growth inhibition of transformed mouse fibroblasts by adenine nucleotides occurs via generation of extracellular adenosine. J. Biol. Chem. 263:1988;12367-12372
3. Fishman P., Bar-Yehuda S., Vagman L. Adenosine and other low molecular weight factors released by muscle cells inhibit tumor cell growth. Cancer Res. 58:1998;3181-3187
4. Spychala J. Tumor-promoting functions of adenosine. Pharmacol. Ther. 87:2000;161-173
5. Tey H.B., Khoo H.E., Tan C.H. Adenosine modulates cell growth in human epidermoid carcinoma (A431) cells. Biochem. Biophys. Res. Commun. 187:1992;1486-1492
6. Janier M.F., Vanoverschelde J.J., Bergmann S.R. Adenosine protects ischemic and reperfused myocardium by receptor-mediated mechanism. Am. J. Physiol. 264:1993;H163-H170
7. Lelievre V., Caigneaux E., Muller J.-M., Falcon J. Extracellular adenosine deprivation induces epithelial differentiation of HT29 cells: evidence for a concomitant adenosine A1/A2 receptor balance regulation. Eur. J. Pharmacol. 391:2000;21-29
8. Pueyo M.E., Chen Y., D'Angelo G., Michel J.B. Regulation of vascular endothelial growth factor expression by cAMP in rat aortic smooth muscle cells. Exp. Cell Res. 238:1998;354-358
9. Barcz E., Sommer E., Sokolnicka I., Gawrychowski K., Roszkowska-Purska K., Janik P., Skopinska-Rozewska E. The influence of theobromine on angiogenic activity and proangiogenic cytokines production of human ovarian cancer cells. Oncol. Rep. 5:1998;517-520
10. Gu J.-W., Brady A.L., Anand V., Moore M.C., Kelly W.C., Adair T.H. Adenosine upregulates VEGF expression in cultured myocardial vascular smooth muscle cells. Am. J. Physiol. 277:1999;H595-H602
11. Grant M.B., Tarnuzzer R.W., Caballero S., Ozeck M.J., Davis M.I., Spoerri P.E., Feoktistov I., Biogioni I., Shryock J.C., Belardinelli L. Adenosine receptor activation induces vascular endothelial growth factor in human retinal endothelial cells. Circ. Res. 85:1999;699-706
12. -) release by activated human neutrophils. Clin. Immunol. Immunopathol. 42:1987;76-85
13. MacKenzie W.M., Hoskin D.W., Bly J. Adenosine inhibits the adhesion of anti-CD3-activated killer lymphocytes to adenocarcinoma cells through an A3 receptor. Cancer Res. 54:1994;3521-3526
14. Cronstein B.N., Naime D., Firestein G. The antiinflammatory effects of an adenosine kinase inhibitor are mediated by adenosine. Arthritis Rheum. 38:1995;1040-1045
15. Huang S., Apasov S., Koshiba M., Sitkovsky M. Role of A2a extracellular adenosine receptor-mediated signaling in adenosine-mediated inhibition of T-cell activation and expansion. Blood. 90:1997;1600-1610
16. Bouma M.G., van den Wildenberg F.A., Buurman W.A. Adenosine inhibits cytokine release and expression of adhesion molecules by activated human endothelial cells. Am. J. Physiol. 270:1996;C522-C529
17. Hoskin D.W., Butler J.J., Drapeau D., Haeryfar S.M., Blay J. Adenosine acts through an A3 receptor to prevent the induction of murine anti-CD3-activated killer T cells. Int. J. Cancer. 99:2002;386-395
18. Schulte G., Fredholm B.B. Signalling from adenosine receptors to mitogen-activated protein kinases. Cell. Signalling. 15:2003;813-827
19. Khoo H.E., Ho C.L., Chhatwal V.J., Chan S.T., Ngoi S.S., Moochhala S.M. Differential expression of adenosine A1 receptors in colorectal cancer and related mucosa. Cancer Lett. 106:1996;17-21
20. Fishman P., Bar-Yehuda S., Ohana G., Pathak S., Wasserman L., Barer F., Multani A.S. Adenosine acts as an inhibitor of lymphoma cell growth: a major role for the A3 adenosine receptor. Eur. J. Cancer. 36:2000;1452-1458
21. Ohana G., Bar-Yehuda S., Barer F., Fishman P. Differential effect of adenosine on tumor and normal cell growth: focus on the A3 adenosine receptor. J. Cell. Physiol. 186:2001;19-23
22. Fishman P., Bar-Yehuda S., Barer F., Madi L., Multani A.S., Pathak S. The A3 adenosine receptor as a new target for cancer therapy and chemoprotection. Exp. Cell Res. 269:2001;230-236
23. Canbolat O., Durak I., Cetin R., Kavutcu M., Demirci S., Ozturk S. Activities of adenosine deaminase, 5′-nucleotidase, guanase, and cytidine deaminase enzymes in cancerous and non-cancerous human breast tissues. Breast Cancer Res. Treat. 37:1996;189-193
24. Durak I., Cetin R., Canbolat O., Cetin D., Yurtarslani Z., Unal A. Adenosine deaminase, 5′-nucleotidase, guanase and cytidine deaminase activities in gastric tissues from patients with gastric cancer. Cancer Lett. 84:1994;199-202
25. Flocke K., Mannherz H.G. Isolation and characterization of 5′-nucleotidase of a human pancreatic tumor cell line. Biochim. Biophys. Acta. 1076:1991;273-281
26. Fukunaga Y., Evans S.S., Yamamoto M., Ueda Y., Tamura K., Takakuwa T., Gebhard D., Allopenna J., Demaria S., Clarkson B., et al. Increased density of ecto 5′ nucleotidase antigen on leukemic T cells from patients with cutaneous T-cell lymphoma and adult T-cell leukemia/lymphoma. Blood. 74:1989;2486-2492
27. Bardot V., Dutrillaux A.M., Delattre J.Y., Vega F., Poisson M., Dutrillaux B., Luccioni C. Purine and pyrimidine metabolism in human gliomas: relation to chromosomal aberrations. Br. J. Cancer. 70:1994;212-218
28. Fenoglio C., Necchi D., Civallero M., Ceroni M., Nano R. Cytochemical demonstration of nitric oxide synthase and 5′ nucleotidase in human glioblastoma. Anticancer Res. 17:1997;2507-2512
29. Clark C.M., Goodland G.A. Protein and enzyme content of plasma membranes derived from Walker 256 carcinoma cells grown as ascitic or solid tumors. Cancer Lett. 68:1993;91-94
30. Ludwig H.C., Rausch S., Schallock K., Markakis E. Expression of CD 73 (ecto-5′-nucleotidase) in 165 glioblastomas by immunohistochemistry and electronmicroscopic histochemistry. Anticancer Res. 19:1999;1747-1752
31. Spychala J., Mitchell B.S., Barankiewicz J. Adenosine metabolism during phorbol myristate acetate-mediated induction of HL-60 cell differentiation: changes in expression pattern of adenosine kinase, adenosine deaminase, and 5′-nucleotidase. J. Immunol. 158:1997;4947-4952
32. Spychala J., Zimmermann A.G., Mitchell B.S. Tissue-specific regulation of the ecto-5′-nucleotidase promoter: role of a CRE site in mediating repression by the upstream regulatory region. J. Biol. Chem. 274:1999;22705-22712
33. Polakis P. Wnt signaling and cancer. Genes Dev. 14:2000;1837-1851
34. Dornand J., Bonnafous J.C., Favero J., Mani J.C. Ecto- 5′nucleotidase and adenosine deaminase activities of lymphoid cells. Biochem. Med. 28:1982;144-156
35. Martinez-Valdez H., Cohen A. Coordinate regulation of mRNAs encoding adenosine deaminase, purine nucleoside phosphorylase, and terminal deoxynucleotidyltransferase by phorbol esters in human thymocytes. Proc. Natl. Acad. Sci. U.S.A. 85:1988;6900-6903
36. Aronow B.J., Silbiger R.N., Dusing M.R., Stock J.L., Yager K.L., Potter S.S., Hutton J.J., Wiginton D.A. Functional analysis of the human adenosine deaminase gene thymic regulatory region and its ability to generate position-independent transgene expression. Mol. Cell. Biol. 12:1992;4170-4185
37. van de Wetering M., Sancho E., Verweij C., de Lau W., Oving I., Hurlstone A., van der Horn K., Batlle E., Coudreuse D., Haramis A.P., Tjon-Pon-Fong M., Moerer P., van den Born M., Soete G., Pals S., Eilers M., Medema R., Clevers H. The beta-catenin/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells. Cell. 111:2002;241-250
38. Shtutman M., Zhurinsky J., Simcha I., Albanese C., D'Amico M., Pestell R., Ben-Ze'ev A. The cyclin D1 gene is a target of the beta-catenin/Lef-1 pathway. Proc. Natl. Acad. Sci U.S.A. 96:1999;5522-5527
39. Lin D.-Y., Xia W., Wang J.C., Kwong K.Y., Spohn B., Wen Y., Pestell R.G., Hung M.-C. Beta catenin, a nowel prognostic marker for breast cancer: its role in cyclin D1 expression and cancer progression. Proc. Natl. Acad. Sci. U.S.A. 97:2000;4262-4266
40. Takayasu H., Horie H., Hiyama E., Matsunaga T., Hayashi Y., Watanabe Y., Suita S., Kaneko M., Sasaki F., Hashizume K., Ozaki T., Furuuchi K., Tada M., Ohnuma N., Nakagawara A. Frequent deletions and mutations of the beta-catenin gene are associated with overexpression of cyclin D1 and fibronectin and poorly differentiated histology in childhood hepatoblastoma. Clin. Cancer Res. 7:2001;901-908
41. Howe L.R., Subbaramaiah K., Chung W.J., Dannenberg A.J., Brown M.C. Transcriptional activation of cyclooxygenase-2 in Wnt-1-transformed mouse mammary epithelial cells. Cancer Res. 59:2000;1572-1577
42. Mann B., Gelos M., Siedow A., Hanski M.L., Gratchev A., Ilyas M., Bodmer W.F., Moyer M.P., Riecken E.O., Buhr H.J., Hanski V. Target genes of β-catenin-T cell-factor/lymphoid-enhancer-factor signaling in human colorectal carcinomas. Proc. Natl. Acad. Sci. U.S.A. 96:1999;1603-1608
43. Crawford H.C., Fingleton B.M., Rudolph-Owen L.A., Heppner Goss K.J., Rubinfeld B., Polakis P., Matrisian L.M. The metalloproteinase matrilysin is a target of beta-catenin transactivation in intestinal tumors. Oncogene. 18:1999;2883-2891
44. Spychala J.a.M.S.B. Cyclosporin A and FK-506 decrease adenosine kinase activity and adenosine uptake in T-lymphocytes. J. Lab. Clin. Med. 140:2002;84-91
45. Young C.S., Kitamura M., Hardy S., Kitajewski J. Wnt-1 induces growth, cytosolic beta-catenin, and Tcf/Lef transcriptional activation in Rat-1 fibroblasts. Mol. Cell. Biol. 18:1998;2474-2485
46. Mizushima S., Nagata S. pEF-BOS, a powerful mammalian expression vector. Nucleic Acid Res. 18:1990;5322
47. van de Wetering M., Oosterwegel M., Dooijes D., Clevers H. Identification and cloning of TCF-1, a T lymphocyte-specific transcription factor containing a sequence-specific HMG box. EMBO J. 10:1991;123-132
48. Hsu S.C., Galceran J., Grosschedl R. Modulation of transcriptional regulation by LEF-1 in response to Wnt-1 signaling and association with beta-catenin. Mol. Cell. Biol. 18:1998;4807-4818
49. Yegutkin G.G., Henttinen T., Samburski S.S., Spychala J., Jalkanen S. The evidence of two opposite, ATP-generating and ATP-consuming, extracellular pathways on endothelial and lymphoid cells. Biochem. J. 367:2002;121-128
50. Castrop J., van Wichen D., Koomans-Bitter M., van de Wetering M., de Weger R., van Dongen J., Clevers H. The human TCF-1 gene encodes a nuclear DNA-binding protein uniquely expressed in normal and neoplastic T-lineage lymphocytes. Blood. 86:1995;3050-3059
51. Porfiri E., Rubinfeld B., Albert I., Hovanes K., Waterman M., Polakis P. Induction of a beta-catenin-LEF-1 complex by wnt-1 and transforming mutants of beta-catenin. Oncogene. 15:1997;2833-2839
52. Huber O., Korn R., McLaughlin J., Ohsugi M., Herrmann B.G., Kemler R. Nuclear localization of beta-catenin by interaction with transcription factor LEF-1. Mech. Dev. 59:1996;3-10
53. Behrens J., von Kries J.P., Kuhl M., Bruhn L., Wedlich D., Grosschedl R., Birchmeier W. Functional interaction of beta-catenin with the transcription factor LEF-1. Nature. 382:1996;638-642
54. Molenaar M., van de Wetering M., Oosterwegel M., Peterson-Maduro J., Godsave S., Korinek V., Roose J., Destree O., Clevers H. XTcf-3 transcription factor mediates beta-catenin-induced axis formation in Xenopus embryos. Cell. 86:1996;391-399
55. Aoki M., Hecht A., Kruse U., Kemler R., Vogt P.K. Nuclear endpoint of Wnt signaling: neoplastic transformation induced by transactivating lymphoid-enhancing factor 1. Proc. Natl. Acad. Sci. U.S.A. 96:1999;139-144
56. Hernandez-Munain C., Roberts J.L., Krangel M.S. Cooperation among multiple transcription factors is required for access to minimal T-cell receptor alpha-enhancer chromatin in vivo. Mol. Cell. Biol. 18:1998;3223-3233
57. Hecht A., Litterst C.M., Huber O., Kemler R. Functional characterization of multiple transactivating elements in b-catenin, some of which interact with the TATA-binding protein in vitro. J. Biol. Chem. 274:1999;18017-18025
58. Bauer A., Huber O., Kemler R. Pontin52, an interaction partner of b-catenin, binds to the TATA box binding protein. Proc. Natl. Acad. Sci. U.S.A. 95:1998;14787-14792
59. Giese K., Kingsley C., Kirshner J.R., Grosschedl R. Assembly and function of a TCR alpha enhancer complex is dependent on LEF-1-induced DNA bending and multiple protein-protein interactions. Genes Dev. 9:1995;995-1008
60. Mayall T.P., Sheridan P.L., Montminy M.R., Jones K.A. Distinct roles for P-CREB and LEF-1 in TCR alpha enhancer assembly and activation on chromatin templates in vitro. Genes Dev. 11:1997;887-899
61. Ilyas M., Tomlinson I.P.M., Rowan A., Pignatelli M., Bodmer W.F. β-catenin mutations in cell lines established from human colorectal cancers. Proc. Natl. Acad. Sci. U.S.A. 94:1997;10330-10334
62. Morin P.J., Sparks A.B., Korinek V., Barker N., Clevers H., Vogelstein B., Kinzler K.W. Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC. (see comments) Science. 275:1997;1787-1790
63. Picher M., Burch L.H., Hirsh A.J., Spychala J., Boucher R.C. Ecto-5′-nucleotidase and nonspecific alkaline phosphatase. Two AMP-hydrolyzing ectoenzymes with distinct roles in human airways. J. Biol. Chem. 278:2003;13468-13479
64. Bianchi V., Spychala J. Mammalian 5′-nucleotidases. J. Biol. Chem. 278:2003;46195-46198
65. He T.C., Sparks A.B., Rago C., Hermeking H., Zawel L., da Costa L.T., Morin P.J., Vogelstein B., Kinzler K.W. Identification of c-MYC as a target of the APC pathway. Science. 281:1998;1509-1512
66. Van der Heyden M.A.G., Rook M.B., Hermans M.M.P., Rijksen G., Boonstra J., Defize L.H.K., Destree O.H.J. Identification of connexin43 as a functional target for wnt signaling. J. Cell Sci. 111:1998;1741-1749
67. Pennica D., Swanson T.A., Welsh J.W., Roy M.A., Lawrence D.A., Lee J., Brush J., Taneyhill L.A., Deuel B., Lew M., Watanabe C., Cohen R.L., Melhem M.F., Finley G.G., Quirke P., Goddard A.D., Hillan K.J., Gurney A.L., Botstein D., Levine A.J. WISP genes are members of the connective tissue growth factor family that are up-regulated in wnt-1-transformed cells and aberrantly expressed in human colon tumors. Proc. Natl. Acad. Sci. U.S.A. 95:1998;14717-14722
68. Xu L., Corcoran R.B., Welsh J.W., Pennica D., Levine A.J. Wisp-1 is a wnt-1 and beta-catenin-responsive oncogene. Genes Dev. 14:2000;585-595
69. Kavasoe T., Furukawa Y., Daigo Y., Nishiwaki T., Ishiguro H., Fujita M., Satoh S., Miwa N., Nagasawa Y., Miyoshi Y., Ogawa M., Nakamura Y. Isolation and characterization of a novel human gene, DRCTNNB1A, the expression of which is down-regulated by β-catenin. Cancer Res. 60:2000;3354-3358
70. Cavallo R.A., Cox R.T., Moline M.M., Roose J., Polevoy G.A., Clevers H., Peifer M., Bejsovec A. Drosophila Tcf and Groucho interact to repress Wingless signalling activity. Nature. 395:1998;604-608
71. Nusse R. Wnt targets, repression and activation. Trends in Genet. 15:1999;1-3
72. Oh C.K., Neurath M., Cho J.J., Semere T., Metcalfe D.D. Two different negative regulatory elements control the transcription of T-cell activation gene 3 in activated mast cells. Biochem. J. 323:1997;511-519
73. Ujhazy P., Klobusicka M., Babusikova O., Strausbauch P., Mihich E., Ehrke M.J. Ecto-5′-nucleotidase (CD73) in multidrug-resistant cell lines generated by doxorubicin. Int. J. Cancer. 59:1994;83-93
74. Ujhazy P., Berleth E.S., Pietkiewicz J.M., Kitano H., Skaar J.R., Ehrke M.J., Mihich E. Evidence for the involvement of ecto-5′-nucleotidase (CD73) in drug resistance. Int. J. Cancer. 68:1996;493-500
75. Ledoux S., Leroy C., Siegfried G., Prie D., Moullier P., Friedlander G. Overexpression of ecto-5′-nucleotidase promotes P-glycoprotein expression in renal epithelial cells. Kidney Int. 52:1997;953-961
76. Bui T.D., Rankin J., Smith K., Huguet E.L., Ruben S., Strachan T., Harris A.L., Lindsay S. A novel human Wnt gene, WNT10B, maps to 12q13 and is expressed in human breast carcinomas. Oncogene. 14:1997;1249-1253